Document Detail

Severe Heart Failure after Bortezomib Treatment in a Patient with Multiple Myeloma: A Case Report and Review of the Literature.
MedLine Citation:
PMID:  22964848     Owner:  NLM     Status:  Publisher    
Background: Bortezomib is a novel, first-in-class peptide which reversibly inhibits the proteasome and is Food and Drug Administration approved for the treatment of multiple myeloma, non-Hodgkin lymphoma, Waldenström's macroglobulinemia, and systemic light chain amyloidosis, among others. Case Report: Very few cases of bortezomib-induced cardiotoxicity have been reported in the literature, and most of them have been confounded by the previous use of anthracyclins. We reviewed the case of a 56-year-old woman with a medical history of well-controlled hypertension who was newly diagnosed with International Staging System stage I multiple myeloma. She presented with new symptoms of exertional dyspnea, paroxysmal nocturnal dyspnea, and orthopnea after a 4th cycle of a bortezomib/dexamethasone-based chemotherapy. Clinical examination was consistent with heart failure. 2-D echocardiogram showed an left ventricular ejection fraction of 25%, abnormal wall motion, severe eccentric mitral regurgitation, and moderate pericardial effusion. Coronary angiogram showed normal coronaries, and cardiac magnetic resonance did not show delayed gadolinium enhancement. Conclusion: We reviewed the possible mechanisms involved in cardiotoxicity caused by bortezomib, and the diagnostic methods and importance of early identification of this adverse event. Differential diagnoses such as cardiac amyloidosis and viral myocarditis are also discussed. To our knowledge, this is the first case where pericardial effusion and mitral regurgitation were described after bortezomib treatment.
Margarita Bockorny; Saneka Chakravarty; Peter Schulman; Bruno Bockorny; Robert Bona
Related Documents :
17023258 - Power doppler ultrasound in musculoskeletal disease: a systematic review.
21348768 - Pan-resistant acinetobacter baumannii mediastinitis treated successfully with tigecycli...
16867298 - Comparing the results of five lifting analysis tools.
22451778 - Frontal osteomyelitis (pott's puffy tumour) associated with pasteurella multocida-a cas...
11855098 - Cystic tumor of the atrioventricular nodal region.
23725648 - Membranous glomerulonephritis associated with splenic marginal zone lymphoma mimicking ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-04
Journal Detail:
Title:  Acta haematologica     Volume:  128     ISSN:  1421-9662     ISO Abbreviation:  Acta Haematol.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0141053     Medline TA:  Acta Haematol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  244-247     Citation Subset:  -    
Copyright Information:
Copyright © 2012 S. Karger AG, Basel.
University of Connecticut Health Center, West Hartford, Conn., USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Morphine Metabolism in Human Skin Microsomes.
Next Document:  Stimulation of fat accumulation in hepatocytes by PGE(2)-dependent repression of hepatic lipolysis, ...